Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Long-Term Outcomes in Patients with Chronic Myeloid Leukemia in Chronic Phase Receiving Frontline Nilotinib Versus Imatinib: Enestnd 10-Year Analysis

Blood (2019) 134 (Supplement_1): 2924.

https://doi.org/10.1182/blood-2019-128761

Published: 2019

Journal Articles

Enestpath Leukemic Stem Cell (LSC) Sub-Study: Analyzing Characteristics of LSC-Positive Patients and Impact of Switch from Imatinib to Nilotinib Therapy on LSCs in Patients with Chronic Myeloid Leukemia

Fermin Sanchez-Guijo, MD PhD, Sergio Matarraz, Eleni Plata, Miguel Sagüés, Montserrat Cortes, Irena Preloznik Zupan, Monica Crugnola, MD, Giovanni Caocci, MD, Heather Oakervee, BSc, MBBS, MD MRCP, FRCPath, Tobias Gedde-Dahl, Krzysztof Warzocha, Wieslaw W. Jedrzejczak, Slawomira Kyrcz-Krzemien, MD PhD, Alexander Kiani, Sharon Supekar, AnaRita Ferreira, Seema Shah, Juan Luis Steegmann, Michele Baccarani, MD

Blood (2019) 134 (Supplement_1): 4160.

https://doi.org/10.1182/blood-2019-124710

Published: 2019

Journal Articles

Final Results from the Phase 3 Traial Areta Comparing a Novel, Extended-Release Anagrelide Formulation to Placebo in Essential Thrombocythemia Patients with Defined Risk Status

Heinz Gisslinger, MD, Christoph Klade, Kudrat Abdulkadyrov, MD, Slawomira Kyrcz-Krzemien, MD PhD, Elena Karyagina, MD, Anait L. Melikyan, MD PhD, Krzysztof Warzocha, Barbara Grohmann-Izay, MD, Juri Hodisch, MD, Rudolf S. Widmann, PhD BSc, Robert Kralovics, Petro E. Petrides, MD PhD, Jiri Schwarz, MD PhD, Jean-Jacques Kiladjian, MD PhD

Blood (2016) 128 (22): 476.

https://doi.org/10.1182/blood.V128.22.476.476

Published: 2016

Journal Articles

Immune Response in Acute Myeloid Leukemia with Mutated Nucleophosmin

Katerina Kuzelova, PhD, Barbora Brodská, PhD, Jana Marková, Grzegorz Helbig, MD PhD, Slawomira Kyrcz-Krzemien, MD PhD, Petr Cetkovsky, MD MBA, PhD

Blood (2015) 126 (23): 2572.

https://doi.org/10.1182/blood.V126.23.2572.2572

Published: 2015

Journal Articles

No Influence of Post-Transplant Anti-HLA Antibodies on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation from HLA-Mismatched Unrelated Donors

Anna Koclega, MD, PhD, Miroslaw Markiewicz, MD, PhD, Prof., Sylwia Mizia, MSci, Urszula Siekiera, BSci, Alicja Dobrowolska, Monika Dzierzak-Mietla, MD, PhD, Krzysztof Bialas, MD, Slawomira Kyrcz-Krzemien, MD PhD Prof.

Blood (2015) 126 (23): 5538.

https://doi.org/10.1182/blood.V126.23.5538.5538

Published: 2015

Journal Articles

Does Ex Vivo CD34+ Cell Selection Change the Outcome of Systemic Sclerosis Patients Treated with Autologous Hematopoietic Stem Cell Transplantation (AHSCT), an Adwp EBMT Study?

Maria Carolina Oliveira, MD PhD, Myriam Labopin, MD, Jörg Henes, MD PhD, John Moore, MD, Nicoletta Del Papa, MD PhD, Ricca Stanciu, Ioanna Sakellari, MD PhD, Roland Schroers, MD, Hans Ulrich Scherer, MD, Slawomira Kyrcz-Krzemien, MD PhD Prof., Thomas Daikeler, MD, Tobias Alexander, Jürgen Finke, MD, Manuela Badoglio, John A Snowden, MD FRCP, FRCPath, Dominique Farge, MD PhD

Blood (2014) 124 (21): 2517.

https://doi.org/10.1182/blood.V124.21.2517.2517

Published: 2014

Journal Articles

Allo-HSCT from MUD/MRD As a Curative Treatment in Paroxysmal Nocturnal Hemoglobinuria

Miroslaw Markiewicz, MD PhD, Anna Koclega, MD PhD, Monika Dzierzak-Mietla, MD PhD, Patrycja Zielinska, MD PhD, Ewa Mendek-Czajkowska, MD PhD, Krzysztof Bialas, MD, Slawomira Kyrcz-Krzemien, MD PhD Prof.

Blood (2014) 124 (21): 1251.

https://doi.org/10.1182/blood.V124.21.1251.1251

Published: 2014

Journal Articles

Matched and Mismatched Unrelated Donor Versus Unmanipulated Haploidentical Donors for Hematopoietic Cell Transplantation in Acute Leukemia in Remission: A Pair Matched Analysis on Behalf of the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Simona Piemontese, MD, Fabio Ciceri, MD, Myriam Labopin, MD, William Arcese, MD, Slawomira Kyrcz-Krzemien, MD PhD Prof., Stella Santarone, MD, He Huang, MDPhD, Dietrich Beelen, MD, Norbert Claude Gorin, MD PhD, Charles Craddock, MDPhD, Zafer Gulbas, MD, Andrea Bacigalupo, MD, Arnon Nagler, MD, Mohamad Mothy, MD PhD

Blood (2014) 124 (21): 1219.

https://doi.org/10.1182/blood.V124.21.1219.1219

Published: 2014

Journal Articles

Favorable Results of Allo-HSCT from MRD in Patients with Myelofibrosis

Miroslaw Markiewicz, MD PhD, Monika Dzierzak-Mietla, MD PhD, Patrycja Zielinska, MD PhD, Agata Wieczorkiewicz-Kabut, MD PhD, Sylwia Mizia, MSci, Mariusz Matyja, MD, Krzysztof Bialas, MD, Grzegorz Helbig, MD PhD Prof., Anna Koclega, MD PhD, Malwina Rybicka, MD, Lech Sedlak, Tomasz Oleksy, Slawomira Kyrcz-Krzemien, MD PhD Prof.

Blood (2014) 124 (21): 5934.

https://doi.org/10.1182/blood.V124.21.5934.5934

Published: 2014

Journal Articles

Cereblon ( CRBN) Gene Polymorphisms Predict Clinical Response and Progression-Free Survival in Multiple Myeloma Patients Treated with Lenalidomide: A Pharmacogenetic Study of Immense Consortium

Blood (2014) 124 (21): 3628.

https://doi.org/10.1182/blood.V124.21.3628.3628

Published: 2014

Journal Articles

Interim Results From a Phase Ib/IIa Clinical Trial with the Soluble Fc-Gamma IIb Receptor SM101 for the Treatment of Primary Immune Thrombocytopenia

Tatyana Semenovna Konstaninova, Ivanova Valentina Leonidovna, Andrzej Hellmann, Slawomira Kyrcz-Krzemien, MD PhD Prof, Sascha Tillmanns, Peter Sondermann, Peter Buckel

Blood (2012) 120 (21): 3388.

https://doi.org/10.1182/blood.V120.21.3388.3388

Published: 2012

Journal Articles

Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with T-Cell Acute Lymphoblastic Leukemia: A Survey From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

Xavier Cahu, MD, Myriam Labopin, Sebastian Giebel, MD, Gerard Socie, MD, Pr, Dietrich Beelen, Renate Arnold, MD, Mauricette Michallet, MD, PhD, Noel Milpied, MD, Gulsan Sucak, Gunhan Gurman, MD, Slawomira Kyrcz-Krzemien, MD, PhD, Jakob R. Passweg, Ibrahim Yakoub-Agha, MD, PhD, Matthias Stelljes, MD, Jordi Esteve, MD, PhD, Mohamad Mohty, MD, PhD

Blood (2012) 120 (21): 356.

https://doi.org/10.1182/blood.V120.21.356.356

Published: 2012

Journal Articles

Molecular Screening for Hepatitis B and Hepatitis C Viruses in Allogeneic Hematopoietic Stem Cell Transplantation– a Pilot Study

Malgorzata Sobczyk-Kruszelnicka, Miroslaw Markiewicz, MD, PhD, Agata Wieczorkiewicz-Kabut, MD, Agnieszka Wieclawek, Anna Soja, Monika Dzierzak-Mietla, MD, Anna Koclega, Krzysztof Bialas, Slawomira Kyrcz-Krzemien, MD, PhD

Blood (2012) 120 (21): 4494.

https://doi.org/10.1182/blood.V120.21.4494.4494

Published: 2012

Journal Articles

Efficacy and Safety of Conditioning Treatment Using Bendamustine in Autologous Hematopoietic Cell Transplantation in Heavily Pretreated Patient with Lymphoma

Malgorzata Krawczyk-Kulis, Anna Kopinska, Iwona Grygoruk-Wisniowska, Slawomira Kyrcz-Krzemien, MD PhD Prof

Blood (2012) 120 (21): 4537.

https://doi.org/10.1182/blood.V120.21.4537.4537

Published: 2012

Journal Articles

Bendamustine in Monotherapy and in Combination Regimens in the Treatment of Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma – a Retrospective Analysis

Iwona Hus, Dariusz Jawniak, Magdalena Gorska-Kosicka, Aleksandra Butrym, Justyna Dzietczenia, Tomasz Wrobel, Grzegorz Mazur, MD, PhD, Ewa Lech-Maranda, Krzysztof Warzocha, MD, PhD, Anna Waszczuk-Gajda, Wieslaw Wiktor-Jedrzejczak, MD, PhD, Malgorzata Krawczyk-Kulis, Slawomira Kyrcz-Krzemien, MD PhD Prof, Lidia Poplawska, Jan Walewski, Anna Dmoszynska

Blood (2012) 120 (21): 4602.

https://doi.org/10.1182/blood.V120.21.4602.4602

Published: 2012

Journal Articles

Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation From HLA-Mismatched Unrelated Donors

Anna Koclega, Miroslaw Markiewicz, MD, PhD, Urszula Siekiera, PhD, Alicja Dobrowolska, Sylwia Mizia, MSci, Monika Dzierzak-Mietla, MD, Patrycja Zielinska, MD, PhD, Malgorzata Sobczyk-Kruszelnicka, Slawomira Kyrcz-Krzemien, MD PhD Prof

Blood (2012) 120 (21): 4475.

https://doi.org/10.1182/blood.V120.21.4475.4475

Published: 2012

Journal Articles

Daunorubicine, Cytarabine and Cladribine (DAC) Vs Daunorubicine and Cytarabine (DA) Induction Treatment in Elderly Acute Myeloid Leukemia (AML) Patients – Results of the Prospective, Multicenter, Randomized Trial of the Polish Adult Leukemia Group (PALG)

Blood (2012) 120 (21): 3602.

https://doi.org/10.1182/blood.V120.21.3602.3602

Published: 2012

Journal Articles

Influence of Minor Histocompatibility Antigens' Disparities On Graft Versus Host Disease and Overall Survival After Allogeneic Hematopoietic Cell Transplantation From Siblings

Monika Dzierzak-Mietla, MD, Miroslaw Markiewicz, MD, PhD, Urszula Siekiera, PhD, Sylwia Mizia, MSci, Agnieszka Karolczyk, Anna Koclega, Patrycja Zielinska, MD, PhD, Malgorzata Sobczyk-Kruszelnicka, Slawomira Kyrcz-Krzemien, MD PhD Prof

Blood (2012) 120 (21): 4172.

https://doi.org/10.1182/blood.V120.21.4172.4172

Published: 2012

Journal Articles

Autologous Haematopoietic Stem Cell Transplantation Is a Highly Effective Second Line of Treatment for Patients with Diffuse Large B-Cell Lymphoma

Malgorzata Krawczyk-Kulis, Anna Kopinska, Marek Seweryn, Malgorzata Sobczyk-Kruszelnicka, Slawomira Kyrcz-Krzemien, MD, PhD,

Blood (2011) 118 (21): 4519.

https://doi.org/10.1182/blood.V118.21.4519.4519

Published: 2011

Journal Articles

Donor CTLA-4 Gene Polymorphism Associations with Acute GvHD After Allogeneic Hematopoietic Stem Cell Transplantation

Irena Frydecka, MD, PhD, Lidia Karabon, PhD, Edyta Pawlak-Adamska, PhD, Anna Tomkiewicz, MSc, Tomasz Wrobel, prof., Miroslaw Markiewicz, MD, PhD, Slawomira Kyrcz-Krzemien, MD, PhD

Blood (2011) 118 (21): 2010.

https://doi.org/10.1182/blood.V118.21.2010.2010

Published: 2011

NARROW

Long-Term Outcomes in Patients with Chronic Myeloid Leukemia in Chronic Phase Receiving Frontline Nilotinib Versus Imatinib: Enestnd 10-Year Analysis

Enestpath Leukemic Stem Cell (LSC) Sub-Study: Analyzing Characteristics of LSC-Positive Patients and Impact of Switch from Imatinib to Nilotinib Therapy on LSCs in Patients with Chronic Myeloid Leukemia

Final Results from the Phase 3 Traial Areta Comparing a Novel, Extended-Release Anagrelide Formulation to Placebo in Essential Thrombocythemia Patients with Defined Risk Status

Immune Response in Acute Myeloid Leukemia with Mutated Nucleophosmin

No Influence of Post-Transplant Anti-HLA Antibodies on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation from HLA-Mismatched Unrelated Donors

Does Ex Vivo CD34+ Cell Selection Change the Outcome of Systemic Sclerosis Patients Treated with Autologous Hematopoietic Stem Cell Transplantation (AHSCT), an Adwp EBMT Study?

Allo-HSCT from MUD/MRD As a Curative Treatment in Paroxysmal Nocturnal Hemoglobinuria

Matched and Mismatched Unrelated Donor Versus Unmanipulated Haploidentical Donors for Hematopoietic Cell Transplantation in Acute Leukemia in Remission: A Pair Matched Analysis on Behalf of the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Favorable Results of Allo-HSCT from MRD in Patients with Myelofibrosis

Cereblon ( CRBN) Gene Polymorphisms Predict Clinical Response and Progression-Free Survival in Multiple Myeloma Patients Treated with Lenalidomide: A Pharmacogenetic Study of Immense Consortium

Interim Results From a Phase Ib/IIa Clinical Trial with the Soluble Fc-Gamma IIb Receptor SM101 for the Treatment of Primary Immune Thrombocytopenia

Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with T-Cell Acute Lymphoblastic Leukemia: A Survey From the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

Molecular Screening for Hepatitis B and Hepatitis C Viruses in Allogeneic Hematopoietic Stem Cell Transplantation– a Pilot Study

Efficacy and Safety of Conditioning Treatment Using Bendamustine in Autologous Hematopoietic Cell Transplantation in Heavily Pretreated Patient with Lymphoma

Bendamustine in Monotherapy and in Combination Regimens in the Treatment of Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma – a Retrospective Analysis

Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation From HLA-Mismatched Unrelated Donors

Daunorubicine, Cytarabine and Cladribine (DAC) Vs Daunorubicine and Cytarabine (DA) Induction Treatment in Elderly Acute Myeloid Leukemia (AML) Patients – Results of the Prospective, Multicenter, Randomized Trial of the Polish Adult Leukemia Group (PALG)

Influence of Minor Histocompatibility Antigens' Disparities On Graft Versus Host Disease and Overall Survival After Allogeneic Hematopoietic Cell Transplantation From Siblings

Autologous Haematopoietic Stem Cell Transplantation Is a Highly Effective Second Line of Treatment for Patients with Diffuse Large B-Cell Lymphoma

Donor CTLA-4 Gene Polymorphism Associations with Acute GvHD After Allogeneic Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only